← FDA Drug Approvals (Drugs@FDA)

ROCURONIUM BROMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2026-03-04

Drug application

FDA Application #

ANDA220124

Application type

Abbreviated New Drug Application (Generic)

Brand name

ROCURONIUM BROMIDE

Generic name

Rocuronium Bromide

Active ingredients

ROCURONIUM BROMIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

ASPIRO

First approval

2026-03-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown